Skip to main content

Advertisement

SpringerLink
Log in

Assessing the economic burden of breast cancer in a US managed care population

  • Epidemiology
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Background

Breast cancer is the most commonly diagnosed non-skin cancer and second leading cause of cancer deaths among women in the US. This study compared healthcare resource utilization and costs in women with breast cancer to a control group in a managed care population.

Material and methods

Women ≥ 18 years with breast cancer were identified using ICD-9 codes from claims databases of five US health plans during 2004. A randomly matched control group of women without cancer served as a comparator group. Healthcare costs included all medical and pharmacy costs during the year. Comparisons were made using per patient per month (PPPM) costs (total costs per patient within 2004 calendar year/months of eligibility).

Results

10,697 women (mean age 55 years) with breast cancer were identified (prevalence of 250 per 100,000) in 2004, with prevalence increasing with age. Mean attributable PPPM costs associated with breast cancer were $2,896 (median = $1,940) with hospitalization contributing most of the costs ($1,340), followed by pharmacotherapy ($537), and surgical intervention ($470). Mean unadjusted all-cause PPPM total costs were $4,421 (median = $2,964) compared to $3,352 (median = $665) p < 0.0001) for cases and controls respectively. Multivariate analyses controlling for differences in comorbidities showed mean adjusted PPPM costs to be 2.28 times (p < 0.0001) higher than non-breast cancer controls.

Discussion

This study demonstrated that breast cancer treatment was associated with substantial healthcare costs, driven mainly by hospitalizations. Projected annual costs for a breast cancer patient would be at least $12,828 higher than that for women without breast cancer based upon unadjusted cost differences.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brown ML, Lipscomb J, Snyder C (2001) The burden of illness of cancer: economic cost and quality of life. Annu Rev Public Health 22:91–113

    Article  PubMed  CAS  Google Scholar 

  2. Osteen R. Breast Cancer (2001) In: Lenhard R, Osteen R, Gansler T (eds) Clinical oncology. American Cancer Society

  3. American Cancer Society (2006) Cancer Statistics 2006: a presentation from the American Cancer Society. http://www.cancer.org/downloads/STT/Cancer_Statistics_2006_Presentation.ppt#256,1,Cancer Statistics 2006

  4. Jemal A, Murray T, Ward E et al (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10–30

    Article  PubMed  Google Scholar 

  5. Ries L, Eisner M, Kosary C et al (2005) SEER Cancer Statistics Review, 1975–2002. http://seer.cancer.gov/csr/1975_2002/ National Cancer Institute

  6. Smigal C, Jemal A, Ward E et al (2006) Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 56:168–183

    PubMed  Google Scholar 

  7. Elkin EB, Hudis C, Begg CB et al (2005) The effect of changes in tumor size on breast carcinoma survival in the US: 1975–1999. Cancer 104:1149–1157

    Article  PubMed  Google Scholar 

  8. National Comprehensive Cancer Network (2006) NCCN Practical Guidelines in Oncology: Breast Cancer, v.2.2006

  9. Bloom BS, de Pouvourville N, Chhatre S et al (2004) Breast cancer treatment in clinical practice compared to best evidence and practice guidelines. Br J Cancer 90:26–30

    Article  PubMed  CAS  Google Scholar 

  10. Lazovich DA, White E, Thomas DB et al (1991) Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA 266:3433–3438

    Article  PubMed  CAS  Google Scholar 

  11. Malin JL, Schuster MA, Kahn KA et al (2002) Quality of breast cancer care: what do we know? J Clin Oncol 20:4381–4393

    Article  PubMed  Google Scholar 

  12. Fireman BH, Quesenberry CP, Somkin CP et al (1997) Cost of care for cancer in a health maintenance organization. Health Care Financ Rev 18:51–76

    PubMed  CAS  Google Scholar 

  13. Legorreta AP, Brooks RJ, Leibowitz AN et al (1996) Cost of breast cancer treatment. A 4-year longitudinal study. Arch Intern Med 156:2197–2201

    CAS  Google Scholar 

  14. Taplin SH, Barlow W, Urban N et al (1995) Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst 87:417–426

    Article  PubMed  CAS  Google Scholar 

  15. Rao S, Kubisiak J, Gilden D (2004) Cost of illness associated with metastatic breast cancer. Breast Cancer Res Treat 83:25–32

    Article  PubMed  CAS  Google Scholar 

  16. American Cancer Society (2005) Breast Cancer Facts & Figures 2005–2006. http://www.cancer.org/downloads/STT/CAFF2005BrFacspdf2005.pdf

  17. Kutikova L, Bowman L, Chang S et al (2005) The economic burden of lung cancer and the associated costs of treatment failure in the United States. Lung Cancer 50:143–154

    Article  PubMed  Google Scholar 

  18. Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383

    Article  PubMed  CAS  Google Scholar 

  19. Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613–619

    Article  PubMed  CAS  Google Scholar 

  20. Nuttall M, van der MJ, Emberton M (2006) Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery. J Clin Epidemiol 59:265–273

  21. Farley JF, Harley CR, Devine JW (2006) A comparison of comorbidity measurements to predict healthcare expenditures. Am J Manag Care 12:110–119

    PubMed  Google Scholar 

  22. Bernardini J, Callen S, Fried L et al (2004) Inter-rater reliability and annual rescoring of the Charlson comorbidity index. Adv Perit Dial 20:125–127

    PubMed  Google Scholar 

  23. O’Connor GT, Plume SK, Olmstead EM et al (1991) A regional prospective study of in-hospital mortality associated with coronary artery bypass grafting. The Northern New England Cardiovascular Disease Study Group. JAMA 266:803–809

    CAS  Google Scholar 

  24. Roos LL, Sharp SM, Cohen MM et al (1989) Risk adjustment in claims-based research: the search for efficient approaches. J Clin Epidemiol 42:1193–1206

    Article  PubMed  CAS  Google Scholar 

  25. Roos LL, Sharp SM, Cohen MM (1991) Comparing clinical information with claims data: some similarities and differences. J Clin Epidemiol 44:881–888

    Article  PubMed  CAS  Google Scholar 

  26. SEER 2003. SEER Surveillance Epidemiology and End Results. http://seer.cancer.gov/statfacts/html/breast.html. National Cancer Institute

  27. Ballard-Barbash R, Potosky AL, Harlan LC et al (1996) Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 88:716–726

    Article  PubMed  CAS  Google Scholar 

  28. Janjan N, Nattinger A, Young M et al (1993) First-year treatment charges for early-stage vs locally advanced breast cancer. Breast Dis 6:23–27

    Google Scholar 

  29. Baker MS, Kessler LG, Urban N et al (1991) Estimating the treatment costs of breast and lung cancer. Med Care 29:40–49

    Article  PubMed  CAS  Google Scholar 

  30. Warren J, Brown M, Fay M et al (2002) Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings. J Clin Oncol 20:307–331

    Article  PubMed  Google Scholar 

  31. Riley GF, Potosky AL, Lubitz JD et al (1995) Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care 33:828–841

    Article  PubMed  CAS  Google Scholar 

  32. Hewitt M, Simone J (1999) Ensuring quality cancer care. National Academy Press

  33. Silliman RA, Troyan SL, Guadagnoli E et al (1997) The impact of age, marital status, and physician-patient interactions on the care of older women with breast carcinoma. Cancer 80:1326–1334

    Article  PubMed  CAS  Google Scholar 

  34. Brown ML, Riley GF, Schussler N et al (2002) Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care 40:4–17

    Article  Google Scholar 

  35. Munoz E, Shamash F, Friedman M et al (1986) Lumpectomy vs mastectomy. The costs of breast preservation for cancer. Arch Surg 121:1297–1301

    Article  PubMed  CAS  Google Scholar 

  36. Barlow WE, Taplin SH, Yoshida CK et al (2001) Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer. J Natl Cancer Inst 93:447–455

    Article  PubMed  CAS  Google Scholar 

  37. Desch CE, Penberthy LT, Hillner BE et al (1999) A sociodemographic and economic comparison of breast reconstruction, mastectomy, and conservative surgery. Surgery 125:441–447

    PubMed  CAS  Google Scholar 

  38. Potosky AL, Merrill RM, Riley GF et al (1997) Breast cancer survival and treatment in health maintenance organization and fee-for-service settings. J Natl Cancer Inst 89:1683–1691

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

We would like to thank Patti Peeples, RPh, Ph.D and Anita Oshodi for their help in development of this manuscript. This study was sponsored by GlaxoSmithKline.

Author information

Authors and Affiliations

  1. HealthCore, Inc., 800 Delaware Avenue, Fifth Floor, Wilmington, DE, 19801, USA

    John J. Barron & Ralph Quimbo

  2. GlaxoSmithKline, Collegeville, PA, USA

    Prashant T. Nikam & Mayur M. Amonkar

Authors
  1. John J. Barron
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ralph Quimbo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prashant T. Nikam
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mayur M. Amonkar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John J. Barron.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barron, J.J., Quimbo, R., Nikam, P.T. et al. Assessing the economic burden of breast cancer in a US managed care population. Breast Cancer Res Treat 109, 367–377 (2008). https://doi.org/10.1007/s10549-007-9650-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-007-9650-4

Keywords

Search

Navigation